Science · Biotechnology · Strategy

Science. Biotechnology. Impact.

I turn evidence across exosomes, peptides, NAD⁺, neuroscience and health technology into clearer strategy.

EXOSOMESPEPTIDESNAD⁺NEUROSCIENCETÜRKİYE MARKET
01EVIDENCE

What do we know?

02STRATEGY

Where is the value?

03TÜRKİYE

Who matters?

MOLECULAR BIOLOGY·CARDIOVASCULAR·NEUROSCIENCE·BIOTECHNOLOGY·TRANSLATION
ExosomesCell-to-cell communication
MitochondriaCellular energy and stress
Peptide BiologySignalling, receptors and target biology
Cardiac BiologyHeart, vessels and tissue physiology
NeuroscienceNeurons, synapses and signalling
NAD⁺ & MetabolismRedox balance and cellular energy
Translational ResearchFrom mechanism to real-world application

Scientific Focus

Not what is new. What matters.

Mechanism, human evidence, limitations and real translational potential.

Go deeper into the science ↗
01

Exosomes

Cargo · communication · biomarkers · translation

02

Peptides

Signal · target · mechanism · evidence

03

NAD⁺

Energy · redox · mitochondria · ageing

Technology Focus

Selected fields. Clear perspective.

Technologies with scientific meaning and credible real-world value.

Consulting

From science to decisions.

Evidence. Positioning. Türkiye strategy. Explore consulting ↗

Scientific & AcademicLiterature, research framing, scientific communication and evidence assessment.
Biotechnology & TechnologyScientific feasibility, technical assessment and technology positioning.
Market & Business DevelopmentTürkiye market mapping, target institutions, stakeholders and entry strategy.

Working Ecosystem

Right technology. Right institution. Right context.

Scientific value matters when it meets real-world reality.

02

Specialist Clinics & Rehabilitation Centres

Centres evaluating new solutions in neurology, rehabilitation and technology-enabled care.

Discuss the clinical use case ↗

Scientific Foundation

Science, clinical need and market reality at the same table.

I combine a background in biology, pharmacology and neuroscience with field and business-development experience across pharmaceuticals, biotechnology and medical technology.

BiologyScientific foundationPharmacologyMaster’s training and experimental researchNeurodegenerationAlzheimer’s and neuroscience focus
Read the evidenceSeparate what a study actually demonstrates from what it does not.
Understand the marketHospitals, specialist clinics, academic centres and real decision processes.
Stay selectiveFocus on technologies with credible value and sustainable potential.

Scientific Perspective

Read the evidence. Ignore the noise.

Referenced. Critical. Applicable.

01
Neuroscience

Exosomes and microRNA biomarkers in Parkinson’s disease

A critical look at exosomes as biomarkers, carriers of pathology and possible therapeutic platforms in Parkinson’s disease.

Explore the writing ↗
02
Neurodegeneration

Mitochondria and cellular quality control in Alzheimer’s disease

A scientific perspective on mitochondrial dysfunction, proteostasis and cellular stress in Alzheimer’s biology.

Explore the writing ↗
03
Digital Health

The role of artificial intelligence in clinical decision-making

Assessing clinical AI through safety, workflow and real-world applicability rather than algorithm performance alone.

Explore the writing ↗
04
Emerging Technologies

Evidence, applicability and market value in health technology

How a health technology moves from scientific evidence to credible use and a sustainable market model.

Explore the writing ↗

Strategic Cooperation

If you have an idea, let’s clarify the evidence and the route.

Scientific consulting · biotechnology · Türkiye market

Let’s Talk ↗